Colin Hill's Net Worth
$2.39 Million
Who is Colin Hill?
Colin Hill has an estimated net worth of $2.39 Million. This is based on reported shares across multiple companies, which include PPD, Inc., BIOTELEMETRY, INC., and Fulcrum Therapeutics, Inc..
SEC CIK
Colin Hill's CIK is 0001673192
Past Insider Trading and Trends
2020 was Colin Hill's most active year for acquiring shares with 3 total transactions. Colin Hill's most active month to acquire stocks was the month of April. 2020 was Colin Hill's most active year for disposing of shares, totalling 3 transactions. Colin Hill's most active month to dispose stocks was the month of January. 2024 saw Colin Hill paying a total of $0.00 for 60,000 shares, this is the most they've acquired in one year. In 2021 Colin Hill cashed out on 37,984 shares for a total of $2,334,763.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
PPD, Inc. No price found
InvestorColin Hill used to own units in Non-voting common stock and Common stock but no longer holds any shares there. In the year 2020 Colin Hill filed a total of 6 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -16.33K |
$47.50 | -$775,675.00 |
0
|
Dec 8
| |||
Form 4
| +15.28% | 2.16K |
—
|
—
| 16.33K |
Apr 23
| |||
Form 4
| -10.84% | -1.72K |
$31.28 | -$53,868.46 | 14.17K |
Sep 21
| |||
Form 4
| +30.66% | 3.73K |
—
|
—
| 15.89K |
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
| 12.16K |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
BIOTELEMETRY, INC. No price found
InvestorColin Hill used to own units in Common Stock but no longer holds any shares there.acquired a total of 21,698 shares in BIOTELEMETRY, INC., Colin also disposed a total of 21,698 shares of BIOTELEMETRY, INC. equalling to $1,561,274.44.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.65K |
$72.00 | -$1,559,088.00 |
0
|
Feb 9
| |||
Form 4
| +15.12% | 2.84K |
$45.51 | -$864.69 | 21.65K |
May 3 - May 11
| |||
Form 4
| +14.62% | 2.4K |
$52.87 | -$1,321.75 | 18.81K |
May 3 - May 6
| |||
Form 4
| +24.14% | 3.19K |
—
|
—
| 16.41K |
May 4
| |||
Form 4
| +27.38% | 2.84K |
—
|
—
| 13.22K |
May 12
| |||
Form 4
|
∞
| 10.38K |
—
|
—
| 10.38K |
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Fulcrum Therapeutics, Inc. (FULC) Snapshot price: $8.54
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |